Atlas Trials

Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive

Clinical trial NCT03790397 · COMPLETED

Trial details

NCT number
NCT03790397
Sponsor
Fundación GECP
Status
COMPLETED
Study type
OBSERVATIONAL
Non Small Cell Lung Cancer
Start date
2019-02-26
Primary completion
2019-07-15
Enrollment
169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.